Gene · 10468
Papers3,272
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,272
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| From Phenomenon to Essence: A Newly Involved lncRNA Kcnq1ot1 Protective Mechanism of Bone Marrow Mesenchymal Stromal Cells in Liver Cirrhosis. | Adv Sci (Weinh) | 2023 | 37282819 | PubTator, text mining | PubMed |
| The Association Between Sarcopenia and Diabetes: From Pathophysiology Mechanism to Therapeutic Strategy. | Diabetes Metab Syndr Obes | 2023 | 37275941 | PubTator, text mining | PubMed |
| Hepatokines, bile acids and ketone bodies are novel Hormones regulating energy homeostasis. | Front Endocrinol (Lausanne) | 2023 | 37274345 | PubTator, text mining | PubMed |
| Mechanism of immune attack in the progression of obesity-related type 2 diabetes. | World J Diabetes | 2023 | 37273249 | PubTator, text mining | PubMed |
| Exploring the presence of markers of decidualization in the fallopian tubes: a systematic review. | Biol Reprod | 2023 | 37265359 | PubTator, text mining | PubMed |
| Structural insights into the assembly of the agrin/LRP4/MuSK signaling complex. | Proc Natl Acad Sci U S A | 2023 | 37252960 | PubTator, text mining | PubMed |
| Immunostaining of βA-Activin and Follistatin Is Decreased in HPV(+) Cervical Pre-Neoplastic and Neoplastic Lesions. | Viruses | 2023 | 37243119 | PubTator, text mining | PubMed |
| Ozone Therapy versus Hyaluronic Acid Injections for Pain Relief in Patients with Knee Osteoarthritis: Preliminary Findings on Molecular and Clinical Outcomes from a Randomized Controlled Trial. | Int J Mol Sci | 2023 | 37240135 | PubTator, text mining | PubMed |
| Activin A Limits VEGF-Induced Permeability via VE-PTP. | Int J Mol Sci | 2023 | 37240047 | PubTator, text mining | PubMed |
| Evaluating the Adipose Tissue Depth as a Predictor Factor for Gestational Diabetes in Later Pregnancy-A Systematic Review. | Biomedicines | 2023 | 37239163 | PubTator, text mining | PubMed |
| Targeted Proteomic Analysis of Patients with Ascending Thoracic Aortic Aneurysm. | Biomedicines | 2023 | 37238945 | PubTator, text mining | PubMed |
| Encapsulated Allografts Preclude Host Sensitization and Promote Ovarian Endocrine Function in Ovariectomized Young Rhesus Monkeys and Sensitized Mice. | Bioengineering (Basel) | 2023 | 37237620 | PubTator, text mining | PubMed |
| Relationships between longitudinal changes in body composition and bone mineral density in middle-to-older aged Australians. | Osteoporos Int | 2023 | 37233793 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Western Diet-Induced Obesity and Obesity-Related Carcinogenesis-A Narrative Review. | Metabolites | 2023 | 37233716 | PubTator, text mining | PubMed |
| Immunotherapy in Anal Cancer. | Curr Oncol | 2023 | 37232801 | PubTator, text mining | PubMed |
| Plasma protein changes reflect colorectal cancer development and associated inflammation. | Front Oncol | 2023 | 37228491 | PubTator, text mining | PubMed |
| Association between follicle-stimulating hormone and nonalcoholic fatty liver disease in postmenopausal women with type 2 diabetes mellitus. | J Diabetes | 2023 | 37221966 | PubTator, text mining | PubMed |
| Association of activins, follistatins and inhibins with incident hip fracture in women with postmenopausal osteoporosis: a proof of concept, case-control study. | Endocrine | 2023 | 37221430 | PubTator, text mining | PubMed |
| [Molecular therapies: present and future in neuromuscular diseases]. | Nervenarzt | 2023 | 37221259 | PubTator, text mining | PubMed |
| Fortetropin supplementation prevents the rise in circulating myostatin but not disuse-induced muscle atrophy in young men with limb immobilization: A randomized controlled trial. | PLoS One | 2023 | 37220119 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10468/papers?page=16